{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T18:18:25Z","timestamp":1769969905955,"version":"3.49.0"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>Donor-specific antibodies (DSA) against HLA are an important biomarker predicting graft injury, rejection (Rej), and failure in various solid-organ transplant recipients. However, the impact of DSA with or without histopathological evidence of rejection among pancreas transplant recipients (PTRs) is unknown.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>In this study, we included all PTRs at our center between 2005 and 2020, with pancreas allograft biopsy before March 31, 2021, and with DSA checked within 15 d of the biopsy. PTRs were divided into 4 groups based on the biopsy findings on the index biopsy and DSA status as Rej\u2013\/DSA\u2013, Rej+\/DSA\u2013, Rej\u2013\/DSA+, and Rej+\/DSA+.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>Two hundred two PTRs had a pancreas allograft biopsy during the study period. Thirty-nine were in Rej\u2013\/DSA\u2013, 84 Rej+\/DSA\u2013, 24 Rej\u2013\/DSA+, and 55 Rej+\/DSA+. The mean interval from transplant to index biopsy was not statistically different between the 4 groups. The most common type of rejection was T cell\u2013mediated rejection; however, antibody-mediated rejection was more prevalent in the Rej+\/DSA+ group. At 5 y postbiopsy, the rate of death-censored graft failure (DCGF) for Rej\u2013\/DSA\u2013 was 18%, 24% in Rej+\/DSA\u2013; 17% in Rej\u2013\/DSA+ and 36% in Rej+\/DSA+ (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2009=\u20090.14). In univariate analysis, mixed rejection (hazard ratio [HR], 3.0; 95% confidence intervals [CI], 1.22-7.39; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2009=\u20090.02) along with solitary pancreas transplantation and Rej+\/DSA+ were associated with DCGF. In multivariate analysis, compared with Rej\u2013\/DSA\u2013, Rej+\/DSA+ was significantly associated with DCGF (HR, 2.32; 95% CI, 1.03-5.20; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2009=\u20090.04); however, Rej+\/DSA\u2013 was not (HR, 1.06; 95% CI, 0.32-3.56; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2009=\u20090.92).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>PTRs with pancreas allograft rejection and concomitant DSA have an increased risk of DCGF.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000004133","type":"journal-article","created":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T21:03:20Z","timestamp":1650056600000},"page":"e289-e296","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["The Presence of Donor-specific Antibodies Around the Time of Pancreas Graft Biopsy With Rejection Is Associated With an Increased Risk of Graft Failure"],"prefix":"10.1097","volume":"106","author":[{"given":"Sandesh","family":"Parajuli","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arjang","family":"Djamali","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI."},{"name":"Division of Transplantation, Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Didier","family":"Mandelbrot","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahad","family":"Aziz","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"Radke","sequence":"additional","affiliation":[{"name":"Division of Transplantation, Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dixon","family":"Kaufman","sequence":"additional","affiliation":[{"name":"Division of Transplantation, Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jon","family":"Odorico","sequence":"additional","affiliation":[{"name":"Division of Transplantation, Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,4,14]]},"reference":[{"key":"R1-20250604","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/nrendo.2013.138","article-title":"The current state of pancreas transplantation.","volume":"9","author":"Gruessner","year":"2013","journal-title":"Nat Rev Endocrinol"},{"key":"R2-20250604","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1001\/archsurg.1997.01430250054012","article-title":"Solitary pancreas allografts. The role of percutaneous biopsy and standardized histologic grading of rejection.","volume":"132","author":"Kuo","year":"1997","journal-title":"Arch Surg"},{"key":"R3-20250604","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1111\/j.1600-6143.2011.03729.x","article-title":"Posttransplant donor-specific anti-HLA antibodies negatively impact pancreas transplantation outcome.","volume":"11","author":"Cantarovich","year":"2011","journal-title":"Am J Transplant"},{"key":"R4-20250604","doi-asserted-by":"crossref","first-page":"a015610","DOI":"10.1101\/cshperspect.a015610","article-title":"Pancreas transplantation: solid organ and islet.","volume":"4","author":"Mittal","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"key":"R5-20250604","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s40472-015-0061-x","article-title":"Diagnosis and treatment of pancreas rejection.","volume":"2","author":"Redfield","year":"2015","journal-title":"Curr Transplant Rep"},{"key":"R6-20250604","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/00007890-200202270-00011","article-title":"Pancreas allograft biopsy: safety of percutaneous biopsy-results of a large experience.","volume":"73","author":"Klassen","year":"2002","journal-title":"Transplantation"},{"key":"R7-20250604","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1034\/j.1399-0012.2000.140508.x","article-title":"The role of percutaneous biopsy in detection of pancreatic transplant rejection.","volume":"14","author":"Lee","year":"2000","journal-title":"Clin Transplant"},{"key":"R8-20250604","doi-asserted-by":"crossref","first-page":"388","DOI":"10.2215\/CJN.00900117","article-title":"Optimizing graft survival by pretreatment of the donor.","volume":"12","author":"Feng","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"R9-20250604","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/TP.0b013e3181605cd9","article-title":"A single human leukocyte antigen-antibody test after heart or lung transplantation is predictive of survival.","volume":"85","author":"Morales-Buenrostro","year":"2008","journal-title":"Transplantation"},{"key":"R10-20250604","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1385\/IR:36:1:255","article-title":"HLA antibody analysis: sensitivity, specificity, and clinical significance in solid organ transplantation.","volume":"36","author":"Zeevi","year":"2006","journal-title":"Immunol Res"},{"key":"R11-20250604","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1681\/ASN.2004121130","article-title":"Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation.","volume":"16","author":"Hourmant","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R12-20250604","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1097\/00007890-200103150-00013","article-title":"Acute humoral rejection in renal allograft recipients: I. Incidence, serology and clinical characteristics.","volume":"71","author":"Crespo","year":"2001","journal-title":"Transplantation"},{"key":"R13-20250604","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1681\/ASN.2016030368","article-title":"Value of donor-specific anti-HLA antibody monitoring and characterization for risk stratification of kidney allograft loss.","volume":"28","author":"Viglietti","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"R14-20250604","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/j.1600-6143.2008.02212.x","article-title":"Banff schema for grading pancreas allograft rejection: working proposal by a multi-disciplinary international consensus panel.","volume":"8","author":"Drachenberg","year":"2008","journal-title":"Am J Transplant"},{"key":"R16-20250604","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/tri.13007","article-title":"Concurrent biopsies of both grafts in recipients of simultaneous pancreas and kidney demonstrate high rates of discordance for rejection as well as discordance in type of rejection\u2014a retrospective study.","volume":"31","author":"Parajuli","year":"2018","journal-title":"Transpl Int"},{"key":"R17-20250604","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/MOT.0000000000000146","article-title":"Simultaneous pancreas and kidney transplantation: current trends and future directions.","volume":"20","author":"Redfield","year":"2015","journal-title":"Curr Opin Organ Transplant"},{"key":"R18-20250604","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.trre.2013.07.001","article-title":"Interpretation of HLA single antigen bead assays.","volume":"27","author":"Ellis","year":"2013","journal-title":"Transplant Rev (Orlando)"},{"key":"R19-20250604","first-page":"435","article-title":"Outcomes of pancreas transplant recipients with de novo donor-specific antibodies.","volume":"103","author":"Parajuli","year":"2019","journal-title":"Transplantation"},{"key":"R20-20250604","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1097\/TP.0000000000001125","article-title":"Virtual HLA crossmatching as a means to safely expedite transplantation of imported pancreata.","volume":"100","author":"Eby","year":"2016","journal-title":"Transplantation"},{"key":"R21-20250604","doi-asserted-by":"crossref","first-page":"e13732","DOI":"10.1111\/ctr.13732","article-title":"Outcomes after simultaneous kidney-pancreas versus pancreas after kidney transplantation in the current era.","volume":"33","author":"Parajuli","year":"2019","journal-title":"Clin Transplant"},{"key":"R22-20250604","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1097\/00007890-199706150-00007","article-title":"Evaluation of pancreas transplant needle biopsy: reproducibility and revision of histologic grading system.","volume":"63","author":"Drachenberg","year":"1997","journal-title":"Transplantation"},{"key":"R23-20250604","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1097\/TP.0000000000002694","article-title":"How should pancreas transplant rejection be treated?","volume":"103","author":"Aziz","year":"2019","journal-title":"Transplantation"},{"key":"R24-20250604","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1111\/j.1600-6143.2010.03079.x","article-title":"Pancreas allograft biopsies with positive c4d staining and anti-donor antibodies related to worse outcome for patients.","volume":"10","author":"de Kort","year":"2010","journal-title":"Am J Transplant"},{"key":"R25-20250604","first-page":"1","article-title":"Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation.","volume":"162","author":"Lefaucheur","year":"2009","journal-title":"Contrib Nephrol"},{"key":"R26-20250604","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/ajt.12212","article-title":"De novo donor-specific HLA antibodies decrease patient and graft survival in liver transplant recipients.","volume":"13","author":"Kaneku","year":"2013","journal-title":"Am J Transplant"},{"key":"R27-20250604","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1600-6143.2010.03383.x","article-title":"De novo donor HLA-specific antibodies after heart transplantation are an independent predictor of poor patient survival.","volume":"11","author":"Smith","year":"2011","journal-title":"Am J Transplant"},{"key":"R28-20250604","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1111\/ajt.13407","article-title":"De Novo donor-specific HLA antibodies are associated with rapid loss of graft function following islet transplantation in type 1 diabetes.","volume":"15","author":"Brooks","year":"2015","journal-title":"Am J Transplant"},{"key":"R29-20250604","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.ekir.2019.04.011","article-title":"Donor-specific antibodies in the absence of rejection are not a risk factor for allograft failure.","volume":"4","author":"Parajuli","year":"2019","journal-title":"Kidney Int Rep"},{"key":"R30-20250604","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/ki.2014.75","article-title":"Increased intragraft rejection-associated gene transcripts in patients with donor-specific antibodies and normal biopsies.","volume":"86","author":"Hayde","year":"2014","journal-title":"Kidney Int"},{"key":"R31-20250604","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.gdata.2014.10.005","article-title":"A pathogenesis-based transcript signature in donor-specific antibody-positive kidney transplant patients with normal biopsies.","volume":"2","author":"\u00d3 Broin","year":"2014","journal-title":"Genom Data"},{"key":"R32-20250604","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/ajt.14000","article-title":"Kidney intragraft homing of de novo donor-specific HLA antibodies is an essential step of antibody-mediated damage but not per se predictive of graft loss.","volume":"17","author":"Nocera","year":"2017","journal-title":"Am J Transplant"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004133","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T19:09:10Z","timestamp":1749064150000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,14]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000004133","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4,14]]}}}